Display screen with a graphical user interface
Latest Eli Lilly and Company Patents:
- URI agonist/vasodilator
- Medication delivery device with needle carrier
- ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY-DRUG CONJUGATES AND ANTI-VEGFR-2 ANTIBODIES
- Dose regimens for use of LY3154207 in the treatment of dopaminergic CNS disorders
- Antibodies that bind human and mouse INSL5 and encoding nucleic acids thereof
Description
The FIGURE is a front view of a display screen with a graphical user interface showing the new design.
The broken lines of uneven length show the display screen and form no part of the claimed design.
Claims
The ornamental design for the display screen with a graphical user interface, as shown and described.
Referenced Cited
U.S. Patent Documents
| D709917 | July 29, 2014 | Faulkner |
| D732574 | June 23, 2015 | Capela |
| D759117 | June 14, 2016 | Liang |
| D766312 | September 13, 2016 | Hedges |
| D777785 | January 31, 2017 | Kim |
| D823859 | July 24, 2018 | Boyd |
| D854043 | July 16, 2019 | van Zyl |
| D857750 | August 27, 2019 | Rowe |
| D859446 | September 10, 2019 | Westerhold |
| D880497 | April 7, 2020 | Boyd |
| D882625 | April 28, 2020 | Dixit |
| D910072 | February 9, 2021 | Cazamias |
| D931898 | September 28, 2021 | Demar |
Patent History
Patent number: D981451
Type: Grant
Filed: May 13, 2021
Date of Patent: Mar 21, 2023
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventor: Korey Allen Clements (Fishers, IN)
Primary Examiner: Nicole C Shiflet
Application Number: 29/783,501
Type: Grant
Filed: May 13, 2021
Date of Patent: Mar 21, 2023
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventor: Korey Allen Clements (Fishers, IN)
Primary Examiner: Nicole C Shiflet
Application Number: 29/783,501
Classifications
Current U.S. Class:
Humanoid (D14/495)
